
Artivion Inc
Healthcare · USD
Price
$33.38
Cap
$1.6B
Earnings
4/4 beat
30d Trend
-2%
Lower half of range — may offer entry value
Target range: $41 – $58 (consensus: $51.43)
Consensus: Buy
Earnings history
Q4 2025
BEAT
0.17 vs 0.16
Q3 2025
BEAT
0.16 vs 0.03
Q2 2025
BEAT
0.24 vs 0.11
Q1 2025
BEAT
0.06 vs 0
Key macro factors
Healthcare Spending Trends & Regulatory Environment: Artivion, as a medical device company, is directly impacted by broader healthcare spending patterns, which are influenced by economic conditions and government policies regarding device approvals and reimbursement.
Global Economic Growth Outlook: The potential downgrade of global growth forecasts by the IMF, partly due to the Middle East conflict, could reduce discretionary healthcare spending and the capacity of international healthcare systems to invest in new technologies, thus affecting Artivion's global sales.
Supply Chain Resilience: Geopolitical tensions, such as the Middle East conflict, can cause increased oil prices and disruptions in global shipping, potentially escalating the manufacturing and distribution costs for Artivion's medical devices and implantable tissues.
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide, focusing on aortic repair.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
